Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain

Nov. 10, 1998

Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy

Nov. 10, 1998

Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week

Nov. 10, 1998

RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist

Nov. 10, 1998

Knoll's promising new treatment for RA covered in depth at rheumatology congress

Nov. 10, 1998

Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist

Nov. 10, 1998

LY-203638 has potent profibrinolytic effects in canine model of thrombosis

Nov. 10, 1998

Specific MC4 receptor agonist reduces food intake in leptin-deficient and -resistant mice

Nov. 10, 1998

Canadian team describes cardioprotective activity of AAA-135

Nov. 10, 1998

WAY-135433 increases HDL cholesterol, protects against atherosclerosis and heart disease

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.